|Global Edition

S&P 500 7,215 +1.07%NASDAQ 24,924 +1.05%BTC $76,415 +1.27%ETH $2,264 +1.61%SOL $83.22 +1.31%EUR/USD 1.1741 +0.20%GOLD 4,631 +1.88%S&P 500 7,215 +1.07%NASDAQ 24,924 +1.05%BTC $76,415 +1.27%ETH $2,264 +1.61%SOL $83.22 +1.31%EUR/USD 1.1741 +0.20%GOLD 4,631 +1.88%

GlobalMarkets

Today

Finance

Eli Lilly Q1 2026 slides: incretin dominance drives 56% revenue surge

Investing.com

April 30, 2026·1 min read

Image: Investing.com

Eli Lilly Q1 2026 slides: incretin dominance drives 56% revenue surge

Original article

Eli Lilly Q1 2026 slides: incretin dominance drives 56% revenue surge

Published by Investing.com

Read full article